STOCK TITAN
  1. Home
  2. Sec-filings
  3. SLN
  4. [Form 4] Silence Therapeutics Plc American Depository Share Insider Trading Activity

[Form 4] Silence Therapeutics Plc American Depository Share Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock SLN logo
Silence Therapeutics Plc

NASDAQ:SLN

SLN Rankings

#5598 Ranked by Market Cap
N/A Ranked by Dividends

SLN Latest News

Jun 12, 2025
Silence Therapeutics Presents Additional Phase 1 Data Highlighting Promise of Divesiran as the Potential First-in-Class siRNA Treatment for Polycythemia Vera
May 8, 2025
Silence Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights
May 6, 2025
Silence Therapeutics Welcomes Tim McInerney to Board of Directors
Mar 5, 2025
Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference
Feb 27, 2025
Silence Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

SLN Latest SEC Filings

Jul 10, 2025
[Form 4] Silence Therapeutics Plc American Depository Share Insider Trading Activity
Jun 30, 2025
[Form 4] Silence Therapeutics Plc American Depository Share Insider Trading Activity
Jun 27, 2025
[8-K] Silence Therapeutics Plc American Depository Share Reports Material Event
Jun 25, 2025
[SCHEDULE 13D/A] Silence Therapeutics Plc American Depository Share SEC Filing
Jun 25, 2025
[Form 4] Silence Therapeutics Plc American Depository Share Insider Trading Activity

SLN Stock Data

303.22M
34.57M
13.57%
54.9%
2.97%
Biotechnology
Pharmaceutical Preparations
Link
United Kingdom
LONDON